Testosterone 00591-3524-30
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Gel
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- October 12, 2017
- Listing Expires
- December 31, 2027
- Application
- ANDA091073
Active Ingredients
| Ingredient | Strength |
|---|---|
| Testosterone | 50 mg/5g |
Drug Class
Androgen [EPC]Androgen Receptor Agonists [MoA]Androgen [EPC]
Selected Package
00591-3524-30Selected30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26)